How well do coverage surveys and programmatically reported mass drug administration coverage match? Results from 214 mass drug administration campaigns in 15 countries, 2008–2017

INTRODUCTION: Delivering preventive chemotherapy through mass drug administration (MDA) is a central approach in controlling or eliminating several neglected tropical diseases (NTDs). Treatment coverage, a primary indicator of MDA performance, can be measured through routinely reported programmatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoerhoff, Kathryn L, Mbabazi, Pamela S, Gass, Katherine, Kraemer, John, Fuller, Brian B, Blair, Lynsey, Bougma, Roland, Meite, Aboulaye, Negussu, Nebiyu, Gashaw, Bizuayehu, Nash, Scott D, Biritwum, Nana-Kwadwo, Lemoine, Jean Frantz, Ullyartha Pangaribuan, Helena, Wijayanti, Eksi, Kollie, Karsor, Rasoamanamihaja, Clara Fabienne, Juziwelo, Lazarus, Mkwanda, Square, Rimal, Pradip, Gnandou, Issa, Diop, Bocar, Dorkenoo, Ameyo Monique, Bronzan, Rachel, Tukahebwa, Edridah Muheki, Kabole, Fatima, Yevstigneyeva, Violetta, Bisanzio, Donal, Courtney, Lauren, Koroma, Joseph, Endayishimye, Egide, Reithinger, Richard, Baker, Margaret C, Fleming, Fiona M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163531/
https://www.ncbi.nlm.nih.gov/pubmed/37142297
http://dx.doi.org/10.1136/bmjgh-2022-011193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163531/
https://www.ncbi.nlm.nih.gov/pubmed/37142297
http://dx.doi.org/10.1136/bmjgh-2022-011193

Ejemplares similares